Derikonjic M, Vekic J, Stefanovic A, Matutinovic M, Munjas J, Antonic T
Sci Rep. 2025; 15(1):5716.
PMID: 39962221
PMC: 11832930.
DOI: 10.1038/s41598-025-90168-z.
Lin Z, Yi T, Hu F, Chen J, Chen L
Front Cardiovasc Med. 2025; 11:1524465.
PMID: 39866802
PMC: 11759299.
DOI: 10.3389/fcvm.2024.1524465.
Rasaei N, Fatemi S, Gholami F, Samadi M, Keshavarz Mohammadian M, Daneshzad E
BMC Med Genomics. 2025; 18(1):16.
PMID: 39838481
PMC: 11753101.
DOI: 10.1186/s12920-024-02066-4.
Orozco Morales J, Medina Urrutia A, Tamayo M, Reyes Barrera J, Galarza E, Juarez Rojas J
Front Pediatr. 2025; 12():1462406.
PMID: 39776642
PMC: 11703661.
DOI: 10.3389/fped.2024.1462406.
Bacchetti T, Morresi C, Simonetti O, Ferretti G
Molecules. 2025; 29(24.
PMID: 39770044
PMC: 11677490.
DOI: 10.3390/molecules29245955.
U-shaped association of uric acid to HDL cholesterol ratio (UHR) with ALL-cause and cardiovascular mortality in diabetic patients: NHANES 1999-2018.
Huang X, Hu L, Li J, Wang X
BMC Cardiovasc Disord. 2024; 24(1):744.
PMID: 39725874
PMC: 11674183.
DOI: 10.1186/s12872-024-04436-3.
Epigenome-wide mediation analysis of the relationship between psychosocial stress and cardiometabolic risk factors in the Health and Retirement Study (HRS).
Opsasnick L, Zhao W, Ratliff S, Du J, Faul J, Schmitz L
Clin Epigenetics. 2024; 16(1):180.
PMID: 39695878
PMC: 11656575.
DOI: 10.1186/s13148-024-01799-4.
H-NMR metabolomics identifies three distinct metabolic profiles differentially associated with cardiometabolic risk in patients with obesity in the Di@bet.es cohort.
Ozcariz E, Guardiola M, Amigo N, Valdes S, Oualla-Bachiri W, Rehues P
Cardiovasc Diabetol. 2024; 23(1):402.
PMID: 39511627
PMC: 11545907.
DOI: 10.1186/s12933-024-02488-5.
Efficacy of Food Industry By-Product β-Glucan/Chitin-Chitosan on Lipid Profile of Overweight and Obese Individuals: Sustainability and Nutraceuticals.
Santisteban V, Munoz-Garcia N, Lopez-Yerena A, Puntes M, Badimon L, Padro T
Nutrients. 2024; 16(19).
PMID: 39408385
PMC: 11478763.
DOI: 10.3390/nu16193420.
Sex-Related Differences in the Associations between Adiponectin and Serum Lipoproteins in Healthy Subjects and Patients with Metabolic Syndrome.
Klobucar I, Habisch H, Klobucar L, Trbusic M, Pregartner G, Berghold A
Biomedicines. 2024; 12(9).
PMID: 39335486
PMC: 11429094.
DOI: 10.3390/biomedicines12091972.
Characteristics, Physiopathology and Management of Dyslipidemias in Pregnancy: A Narrative Review.
Formisano E, Proietti E, Perrone G, Demarco V, Galoppi P, Stefanutti C
Nutrients. 2024; 16(17).
PMID: 39275243
PMC: 11397408.
DOI: 10.3390/nu16172927.
Nuclear-Magnetic-Resonance-Spectroscopy-Derived Serum Biomarkers of Metabolic Vulnerability Are Associated with Disability and Neurodegeneration in Multiple Sclerosis.
Wicks T, Shalaurova I, Browne R, Wolska A, Weinstock-Guttman B, Zivadinov R
Nutrients. 2024; 16(17).
PMID: 39275183
PMC: 11396879.
DOI: 10.3390/nu16172866.
Profound perturbations are found in the proteome and metabolome in children with obesity after weight loss intervention.
Liu X, Wang H, Zhu L
Heliyon. 2024; 10(11):e31917.
PMID: 38867950
PMC: 11167357.
DOI: 10.1016/j.heliyon.2024.e31917.
New advances of adiponectin in regulating obesity and related metabolic syndromes.
Han Y, Sun Q, Chen W, Gao Y, Ye J, Chen Y
J Pharm Anal. 2024; 14(5):100913.
PMID: 38799237
PMC: 11127227.
DOI: 10.1016/j.jpha.2023.12.003.
HDL-Cholesterol Subfraction Dimensional Distribution Is Associated with Cardiovascular Disease Risk and Is Predicted by Visceral Adiposity and Dietary Lipid Intake in Women.
Sergi D, Sanz J, Trentini A, Bonaccorsi G, Angelini S, Castaldo F
Nutrients. 2024; 16(10).
PMID: 38794763
PMC: 11124017.
DOI: 10.3390/nu16101525.
Serum Levels of Adiponectin Are Strongly Associated with Lipoprotein Subclasses in Healthy Volunteers but Not in Patients with Metabolic Syndrome.
Klobucar I, Habisch H, Klobucar L, Trbusic M, Pregartner G, Berghold A
Int J Mol Sci. 2024; 25(9).
PMID: 38732266
PMC: 11084877.
DOI: 10.3390/ijms25095050.
Advanced Oxidation Protein Products Are Strongly Associated with the Serum Levels and Lipid Contents of Lipoprotein Subclasses in Healthy Volunteers and Patients with Metabolic Syndrome.
Klobucar I, Hofmann L, Habisch H, Lechleitner M, Klobucar L, Trbusic M
Antioxidants (Basel). 2024; 13(3).
PMID: 38539872
PMC: 10968302.
DOI: 10.3390/antiox13030339.
Observational study on obesity: Insights from middle-aged and elderly college staff in Beijing.
Zhang C, Jing H, Li Y, Li X, Xie G, Liang J
Medicine (Baltimore). 2024; 102(52):e36792.
PMID: 38206751
PMC: 10754573.
DOI: 10.1097/MD.0000000000036792.
Effects of Seven Weeks of Combined Physical Training on High-Density Lipoprotein Functionality in Overweight/Obese Subjects.
Bacchetti T, Morresi C, Ferretti G, Larsson A, Akerfeldt T, Svensson M
Metabolites. 2023; 13(10).
PMID: 37887393
PMC: 10609075.
DOI: 10.3390/metabo13101068.
The newly proposed alanine aminotransferase to high-density lipoprotein cholesterol ratio has shown effectiveness in identifying non-alcoholic fatty liver disease.
Qiu J, Kuang M, Yang R, Yu C, He S, Sheng G
Front Endocrinol (Lausanne). 2023; 14:1239398.
PMID: 37727457
PMC: 10505795.
DOI: 10.3389/fendo.2023.1239398.